Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 27, 2010

CRYO-CELL International, Inc.

(Exact name of registrant as specified in its charter)


700 Brooker Creek Blvd., Suite 1800, Oldsmar, FL		34677
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (813) 749-2100

Not applicable

(Former name or former address, if changed since last report)

Delaware

0-23386

22-3023093

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

(b) On January 27, 2010, Cryo-Cell International, Inc. (the “Company”) was informed of the untimely death of director Gaby Goubran, who passed away on January 27, 2010. Mr. Goubran served as a director of the Company since 2002 and will be greatly missed.

-2-

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	CRYO-CELL INTERNATIONAL, INC.
	(Registrant)

Date: January 28, 2010	By:	/S/ JILL M. TAYMANS
	Name:	Jill M. Taymans
	Title:	Vice President, Finance

-3-